Olema Pharmaceuticals Inc. (OLMA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Olema Pharmaceuticals Inc...

    NASDAQ: OLMA · Real-Time Price · USD
    7.58
    -0.73 (-8.78%)
    At close: Sep 08, 2025, 3:59 PM
    7.60
    0.26%
    After-hours: Sep 08, 2025, 06:42 PM EDT

    Olema Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 393K 377K 1.66M 1.66M
    Gross Profit
    		 -393K -377K -1.66M -1.66M
    Operating Income
    		 -142.26M -104.96M -106.99M -71.49M
    Interest Income
    		 12.68M 8.32M 2.23M 442K
    Pretax Income
    		 -129.47M -96.66M -104.79M -71.1M
    Net Income
    		 -129.47M -96.66M -104.79M -70.89M
    Selling & General & Admin
    		 17.74M 18.82M 24.71M 20.39M
    Research & Development
    		 124.52M 86.14M 82.27M 51.1M
    Other Expenses
    		 n/a n/a -27K -47K
    Operating Expenses
    		 142.26M 104.58M 106.99M 71.49M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -142.26M 104.96M 106.99M 71.49M
    Income Tax Expense
    		 n/a n/a n/a -210K
    Shares Outstanding (Basic)
    		 58.74M 45.25M 40M 39.52M
    Shares Outstanding (Diluted)
    		 58.74M 45.25M 40M 39.52M
    EPS (Basic)
    		 -2.2 -2.14 -2.62 -1.79
    EPS (Diluted)
    		 -2.2 -2.14 -2.62 -1.79
    EBITDA
    		 -129.08M -104.58M -106.63M -69.43M
    EBIT
    		 -129.47M -96.66M -104.79M -71.1M
    Depreciation & Amortization
    		 393K 377K 357K 1.66M

    Add to Watchlist